{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T15:49:46Z","timestamp":1785426586200,"version":"3.56.0"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,1,7]]},"DOI":"10.7759\/cureus.77106","type":"journal-article","created":{"date-parts":[[2025,1,8]],"date-time":"2025-01-08T00:37:28Z","timestamp":1736296648000},"source":"Crossref","is-referenced-by-count":1,"title":["The Use of Glucagon-Like Peptide-1 (GLP-1) Agonists in the Perioperative Period: A Case Study"],"prefix":"10.7759","author":[{"given":"Todd R","family":"Anderson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Bushhouse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily J","family":"Carletto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly","family":"Holder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj-2023-076410","article-title":"Comparative effectiveness of GLP-1 receptor agonists on glycaemic control, body weight, and lipid profile for type 2 diabetes: systematic review and network meta-analysis","volume":"384","author":"Yao H","year":"2024","unstructured":"Yao H, Zhang A, Li D, Wu Y, Wang CZ, Wan JY, Yuan CS. Comparative effectiveness of GLP-1 receptor agonists on glycaemic control, body weight, and lipid profile for type 2 diabetes: systematic review and network meta-analysis. BMJ. 2024, 384:e076410. 10.1136\/bmj-2023-076410","journal-title":"BMJ"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.123.067584","article-title":"Estimated lifetime cardiovascular, kidney, and mortality benefits of combination treatment with SGLT2 inhibitors, GLP-1 receptor agonists, and nonsteroidal MRA compared with conventional care in patients with type 2 diabetes and albuminuria","volume":"149","author":"Neuen BL","year":"2024","unstructured":"Neuen BL, Heerspink HJ, Vart P, et al.. Estimated lifetime cardiovascular, kidney, and mortality benefits of combination treatment with SGLT2 inhibitors, GLP-1 receptor agonists, and nonsteroidal MRA compared with conventional care in patients with type 2 diabetes and albuminuria. Circulation. 2024, 149:450-62. 10.1161\/CIRCULATIONAHA.123.067584","journal-title":"Circulation"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.1043789","article-title":"Association between different GLP-1 receptor agonists and gastrointestinal adverse reactions: A real-world disproportionality study based on FDA adverse event reporting system database","volume":"13","author":"Liu L","year":"2022","unstructured":"Liu L, Chen J, Wang L, Chen C, Chen L. Association between different GLP-1 receptor agonists and gastrointestinal adverse reactions: A real-world disproportionality study based on FDA adverse event reporting system database. Front Endocrinol (Lausanne). 2022, 13:1043789. 10.3389\/fendo.2022.1043789","journal-title":"Front Endocrinol (Lausanne)"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1900\/RDS.2014.11.202","article-title":"Adverse effects of GLP-1 receptor agonists","volume":"11","author":"Filippatos TD","year":"2014","unstructured":"Filippatos TD, Panagiotopoulou TV, Elisaf MS. Adverse effects of GLP-1 receptor agonists. Rev Diabet Stud. 2014, 11:202-30. 10.1900\/RDS.2014.11.202","journal-title":"Rev Diabet Stud"},{"key":"ref5","unstructured":"American Society of Anesthesiologists consensus-based guidance on preoperative management of patients (adults and children) on glucagon-like peptide-1 (GLP-1) receptor agonists. (2025). Accessed. November 15, 2024: https:\/\/www.asahq.org\/about-asa\/newsroom\/news-releases\/2023\/06\/american-society-of-anesthesiologists-consensus-based-...."},{"key":"ref6","unstructured":"More about use of GLP-1 receptor agonists just before elective surgery. (2025). Accessed. November 15, 2024: https:\/\/www.jwatch.org\/na57681\/2024\/07\/11\/more-about-use-glp-1-receptor-agonists-just-before."},{"key":"ref7","unstructured":"Study challenges seven-day hold on GLP-1 agonists before surgery. (2025). Accessed. November 15, 2024: https:\/\/www.houstonmethodist.org\/leading-medicine-blog\/articles\/2024\/jul\/study-challenges-seven-day-hold-on-glp-1-ago...."},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.jviscsurg.2016.08.010","article-title":"Postoperative ileus: pathophysiology, incidence, and prevention","volume":"153","author":"Venara A","year":"2016","unstructured":"Venara A, Neunlist M, Slim K, Barbieux J, Colas PA, Hamy A, Meurette G. Postoperative ileus: pathophysiology, incidence, and prevention. J Visc Surg. 2016, 153:439-46. 10.1016\/j.jviscsurg.2016.08.010","journal-title":"J Visc Surg"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1007\/s00384-020-03698-5","article-title":"Incidence and risk factors of postoperative ileus after hysterectomy for benign indications","volume":"35","author":"Li ZL","year":"2020","unstructured":"Li ZL, Zhao BC, Deng WT, Zhuang PP, Liu WF, Li C, Liu KX. Incidence and risk factors of postoperative ileus after hysterectomy for benign indications. Int J Colorectal Dis. 2020, 35:2105-12. 10.1007\/s00384-020-03698-5","journal-title":"Int J Colorectal Dis"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.4293\/JSLS.2016.00073","article-title":"Small-bowel obstruction secondary to adhesions after open or laparoscopic colorectal surgery","volume":"20","author":"Smolarek S","year":"2016","unstructured":"Smolarek S, Shalaby M, Paolo Angelucci G, et al.. Small-bowel obstruction secondary to adhesions after open or laparoscopic colorectal surgery. JSLS. 2016, 20:10.4293\/JSLS.2016.00073","journal-title":"JSLS"},{"key":"ref11","unstructured":"Small bowel follow-through. (2025). Accessed. November 16, 2024: https:\/\/www.radiologyinfo.org\/en\/info\/small-bowel-follow-thru."},{"key":"ref12","unstructured":"Small bowel follow-through. (2025). Accessed. November 16, 2024: https:\/\/muschealth.org\/medical-services\/ddc\/patients\/medical-tests\/barium-radiology\/small-bowel-follow-through."},{"key":"ref13","article-title":"Postoperative Ileus","author":"Buchanan L","year":"2023","unstructured":"Buchanan L, Tuma F. Postoperative Ileus. StatPearls Publishing, Treasure Island, FL; 2023."},{"key":"ref14","unstructured":"Bowel obstruction. Signs & symptoms, causes, treatment. (2025). Accessed: November 16, 2024: https:\/\/my.clevelandclinic.org\/health\/diseases\/bowel-obstruction."},{"key":"ref15","article-title":"Tirzepatide","author":"Farzam K","year":"2024","unstructured":"Farzam K, Patel P. Tirzepatide. StatPearls Publishing, Treasure Island, FL; 2024."}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/331861-the-use-of-glucagon-like-peptide-1-glp-1-agonists-in-the-perioperative-period-a-case-study","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,8]],"date-time":"2025-01-08T00:37:32Z","timestamp":1736296652000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/331861-the-use-of-glucagon-like-peptide-1-glp-1-agonists-in-the-perioperative-period-a-case-study"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,7]]},"references-count":15,"URL":"https:\/\/doi.org\/10.7759\/cureus.77106","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1,7]]}}}